BRIEF published on 12/20/2024 at 14:59, 1 year 8 months ago Le groupe Vanguard dévoile sa participation dans Direct Line Insurance Groupe Vanguard Code De Prise De Contrôle Vente D'actions Divulgation Des Enjeux Assurance Ligne Directe
PRESS RELEASE published on 12/20/2024 at 14:54, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.48% interest in Direct Line Insurance Group plc as of 19 Dec 2024. Additional disclosures include dealings and positions in relevant securities Securities Disclosure Vanguard Group Dealings Direct Line Insurance Group
BRIEF published on 12/13/2024 at 15:38, 1 year 8 months ago Vanguard Group Discloses Position in Direct Line Insurance Takeover Code Vanguard Group Financial Disclosure Shareholding Direct Line Insurance
BRIEF published on 12/13/2024 at 15:38, 1 year 8 months ago Le groupe Vanguard dévoile sa position dans Direct Line Insurance Actionnariat Groupe Vanguard Code De Prise De Contrôle Divulgation Financière Assurance Ligne Directe
PRESS RELEASE published on 12/13/2024 at 15:33, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.48% stake in Direct Line Insurance Group plc as of 12 December 2024 under Rule 8.3 of the Takeover Code The Vanguard Group, Inc. Rule 8.3 Takeover Code Stake Disclosure Direct Line Insurance Group Plc
BRIEF published on 12/12/2024 at 15:50, 1 year 8 months ago Vanguard Group Discloses Stake in Direct Line Insurance Securities Dealings Takeover Code Vanguard Group Stake Disclosure Direct Line Insurance
BRIEF published on 12/12/2024 at 15:50, 1 year 8 months ago Le groupe Vanguard dévoile sa participation dans Direct Line Insurance Groupe Vanguard Code De Prise De Contrôle Divulgation Des Enjeux Opérations Sur Valeurs Mobilières Assurance Ligne Directe
PRESS RELEASE published on 12/12/2024 at 15:45, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. files Form 8.3 disclosing ownership of 5.48% of Direct Line Insurance Group plc. Additional disclosures include dealings and positions held Form 8.3 Vanguard Group Ownership Disclosure Dealings Direct Line Insurance
BRIEF published on 12/06/2024 at 16:07, 1 year 9 months ago The Vanguard Group Discloses Interests in Direct Line Insurance Group Takeover Code Securities Disclosure Vanguard Group Investment Holdings Direct Line Group
BRIEF published on 12/06/2024 at 16:07, 1 year 9 months ago Le groupe Vanguard révèle ses participations dans Direct Line Insurance Group Investissements Groupe Vanguard Code De Prise De Contrôle Divulgation Des Valeurs Mobilières Groupe De Ligne Directe
Published on 09/11/2026 at 04:00, 6 hours 1 minute ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 36 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 41 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 1 minute ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 40 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 55 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 1 minute ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 1 minute ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 31 minutes ago Availability of the 2026 Interim Financial Report
